Hypertension: Diagnostic Test Strategies

References

• U.S. National Center for Health Statistics, Blood Pressure Levels of Persons 6–74 Years of Age in the United States. Vital and Health Statistics. U.S. Government Printing Office, Rockville, Md 1977, Series 11, No. 203
   Google Scholar
• Kannel W. B., Gordon T. The Framingham Study, Section 30, DHEW Publ. No. (NIH) 74–599, National Institute of Health, U.S. Department of Health. Education and Welfare, Washington, DC 1974
   Google Scholar
• Doyle J. T. Risk factors in coronary heart disease. N. Y. State J. Med. 1963; 63: 1317
   Google Scholar
• Chapman J. M., Massey F. J., Jr. The interrelationship of serum cholesterol, hypertension, body weight, and risk of coronary disease: results of first ten years' follow-up in the Los Angeles heart study. J. Chronic Dis. 1964; 17: 933
   PubMedGoogle Scholar
• Veterans Administration Cooperative Study Group on Antihypertensive Agents, Effects of treatment on morbidity in hypertension. I. Results in patients with diastolic blood pressures averaging 115 through 129 mmHg. JAMA 1967; 202: 1028
   PubMed Web of Science ®Google Scholar
• Veterans Administration Cooperative Study Group on Antihypertensive Agents, Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mmHg. JAMA 1970; 213: 1143
   PubMed Web of Science ®Google Scholar
• Langfeld S. B. Hypertension: deficient care of the medically served. Ann. Intern. Med. 1973; 78: 19
   PubMed Web of Science ®Google Scholar
• McKenney J. M., Slining J. M., Henderson H. R., Devins D., Barr M. The effect of clinical pharmacy services on patients with essential hypertension. Circulation 1973; 48: 1104
   PubMed Web of Science ®Google Scholar
• Sackett D. L. Screening for disease: cardiovascular diseases. Lancet 1974; 2: 1189
   PubMed Web of Science ®Google Scholar
• D'Souza M. F., Swan A. V., Shannon D. J. Screening: a long-term controlled trial of screening for hypertension in general practice. Lancet 1976; 1: 1228
   PubMed Web of Science ®Google Scholar
• Moser M. Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure: a cooperative study. JAMA 1977; 237(3)255
   PubMed Web of Science ®Google Scholar
• Stason W. B., Weinstein M. C. Allocation of resources to manage hypertension. N. Engl. J. Med. 1977; 296(13)732
   PubMed Web of Science ®Google Scholar
• Tucker R. M., LaBarthe D. R. Frequency of surgical treatment for hypertension in adults at the Mayo Clinic from 1973 through 1975. Mayo Clin. Proc. 1977; 52: 549
   PubMed Web of Science ®Google Scholar
• Pickering G. W. High Blood Pressure. Churchill Livingstone, London 1955
   Google Scholar
• WHO, Hypertension and coronary heart disease: classification and criteria for epidemiological studies, Tech. Rep. Ser. No. 168. World Health Organization, Geneva 1959
   Google Scholar
• Gifford R. W., Jr. Hypertension 1975. Drug Therapy 1975; 5(5)39
   Google Scholar
• The Task Force on Blood Pressure Control in Children. Pediatrics 1977; 59: 797, Suppl. 5
   Web of Science ®Google Scholar
• Alderman M. H. High blood pressure: do we really know whom to treat and how?. N. Engl. J. Med. 1977; 296: 753
   PubMed Web of Science ®Google Scholar
• Loggie J. M. H. Hypertension in children and adolescents. Hosp. Pract. 1975; 10(6)81
   Google Scholar
• Hypertension Detection and Follow-Up Program Cooperative Group, The hypertension detection and follow-up program. Prev. Med. 1976; 5(2)207
   PubMed Web of Science ®Google Scholar
• Medical Research Council Working Party on Mild to Moderate Hypertension, Randomised controlled trial of treatment for mild hypertension: design and pilot trial. Br. Med. J. 1977; 1: 1437
   PubMed Web of Science ®Google Scholar
• Frohlich E. D., et al. The practical management of hypertension. Current Problems in Cardiology, W. P. Harvey. Year Book Medical Publishing, Chicago 1976; Vol. I
   Google Scholar
• Wilhelmsen L., Berglund G. Prevalence of primary and secondary hypertension. Am. Heart J. 1977; 94: 543
   PubMed Web of Science ®Google Scholar
• Gifford R. W., Jr. Evaluation of the hypertensive patient with emphasis on detecting curable causes. II. Milbank Mem. Fund 1969; 47: 170
   Google Scholar
• McNeil B. J., Varady P. D., Burrows B. A., Adelstein S. J. Measures of clinical efficacy. Cost-effectiveness calculations in the diagnosis and treatment of hypertensive renovascular disease. N. Engl. J. Med. 1975; 293: 216
   PubMed Web of Science ®Google Scholar
• Blacklock J. W. S., Ferguson J. W., Mack W. S., Shofar J., Symington T. Pheochromocytoma. Br. J. Surg. 1947; 35: 179
   PubMedGoogle Scholar
• Berkheiser S. W., Rappoport A. E. Unsuspected pheochromocytoma of the adrenal: report of five cases. Am. J. Clin. Pathol. 1951; 21: 657
   PubMed Web of Science ®Google Scholar
• Kale W. F., Roth G. M., Manger W. M., Priestley J. T. Present-day diagnosis and treatment of pheochromocytoma: a review of fifty-one cases. JAMA 1957; 164: 854
   PubMed Web of Science ®Google Scholar
• Smithwick R. H., Greer W. E. R., Roberston C. W., Wilkins R. W. Pheochromocytoma: a discussion of symptoms, signs and procedures of diagnostic value. N. Engl. J. Med. 1950; 242: 252
   PubMed Web of Science ®Google Scholar
• Conn J. W., Knopf R. F., Nesbit R. M. Clinical characteristics of primary aldosteronism from an analysis of 145 cases. Am. J. Surg. 1964; 107: 159
   PubMed Web of Science ®Google Scholar
• Conn J. W. Primary aldosteronism and primary reninism. Hosp. Pract. 1974; 9(10)131
   Web of Science ®Google Scholar
• Page I. H. Arterial hypertension in retrospect. Circ. Res. 1974; 34: 133
   PubMed Web of Science ®Google Scholar
• Edis A. J., Shepherd J. T. Autonomic control of the peripheral vascular system. Arch. Intern. Med. 1970; 125: 716
   PubMedGoogle Scholar
• Frohlich E. D. The adrenergic nervous system and hypertension: state of the art, 2nd Pan American Symp. on Hypertension—Part II. Mayo Clin. Proc. 1977; 52: 361
   PubMed Web of Science ®Google Scholar
• Guyton A. C. Regulation of mean arterial pressure. I. Nervous reflex and hormonal mechanisms for rapid pressure control. Basic Human Physiology: Normal Function and Mechanisms of Disease. W. B. Saunders, Philadelphia 1977; 17
   Google Scholar
• Pfeffer M. A., Frohlich E. D. Hemodynamics of spontaneously hypertensive rats. 1. Effects of pressure elevation. Am. J. Physiol. 1973; 224: 1066
   PubMed Web of Science ®Google Scholar
• Kezdi P., Kordenat R. K. Systemic and cardiac mechanoreceptors in arterial hypertension. The Nervous System in Arterial Hypertension, S. Julius, M. D. Eslen. Charles C Thomas, SpringfieldI ll 1976; 207
   Google Scholar
• Kopin I. J. Catecholamine metabolism (and the biochemical assessment of sympathetic activity). Clin. Endocrinol. Metab. 1977; 6(3)525
   PubMedGoogle Scholar
• Axelrod J. Purification and properties of phenylethanolamine-N-methyl transferase. J. Biol. Chem. 1962; 237: 1657
   PubMed Web of Science ®Google Scholar
• Perlman R. L., Chalfie M. Catecholamine release from the adrenal medulla. Clin. Endocrinol. Metab. 1977; 6(3)551
   PubMedGoogle Scholar
• Burn J. H., Gibbons W. R. The release of noradrenalin from sympathetic nerve fibres in relation to calcium concentration. J. Physiol. (London) 1965; 181: 214
   Google Scholar
• Smith A. D., Winkler H. Fundamental mechanisms in the release of catecholamines. Catecholamines Handbook of Experimental Pharmacology, H. Blaschko, E. Muscholl. Springer-Verlag, Basel 1972; Vol. 33: 538
   Google Scholar
• Gewirtz G. P., Kopin I. J. Release of dopamine-β-hydroxylase with norepinephrine by splenic nerve stimulation. Nature (London) 1970; 227: 406
   PubMed Web of Science ®Google Scholar
• Anon. Catecholamines in essential hypertension, (Editorial). Lancet 1977; 1: 1088
   PubMed Web of Science ®Google Scholar
• Engelman K. Isotopic methods of assay of catecholamines and their metabolites. Methods in Investigative and Diagnostic Endocrinology, J. E. Rall, I. J. Kopin. North-Holland, Amsterdam 1972; Vol. 1: 437
   Google Scholar
• Haber E. The role of renin in normal and pathological cardiovascular homeostasis. Circulation 1976; 54(6)849
   PubMed Web of Science ®Google Scholar
• Edelman R., Hartroft P. M. Localization of renin in juxtaglomerular cells of rabbit and dog through the use of the fluorescent-antibody technique. Circ. Res. 1961; 9: 1069
   Web of Science ®Google Scholar
• Oparil S., Haber E. The renin-angiotensin system. N. Engl. J. Med. 1974; 291: 389
   PubMed Web of Science ®Google Scholar
• Khairallah P. A., Toth A., Bumpus F. M. Analogs of angiotensin II. II. Mechanisms of receptor interaction. J. Med. Chem. 1970; 13: 181
   PubMed Web of Science ®Google Scholar
• Streeten D. H., Anderson G. H., Freiberg J. M., Dalakos T. G. Use of an angiotensin II antagonist (saralasin) in the recognition of “angiotensinogenic” hypertension. N. Engl. J. Med. 1965; 292: 657
   Google Scholar
• Hollenberg N. K., Williams G. H., Burger B., Ishiwaka I., Adams D. F. Blockade and stimulation of renal, adrenal and vascular angiotensin II receptors with 1-Sar, 8-Ala angiotensin II in normal man. J. Clin. Invest. 1976; 57: 39
   PubMed Web of Science ®Google Scholar
• Ondetti M. A., Williams N. J., Sabo E. F., Pluscec J., Weaver E. R., Kocy O. Angiotensin-converting enzyme inhibitors from the venom Bothrops jararaca: isolation, elucidation of structure, and synthesis. Biochemistry 1971; 10: 4033
   PubMed Web of Science ®Google Scholar
• Sancho J., Re R., Burton J., Barger A. C., Haber E. The role of the renin-angiotensinaldosterone system in cardiovascular homeostasis in normal human subjects. Circulation 1976; 53: 400
   PubMed Web of Science ®Google Scholar
• Ondetti M. A., Rubin B., Cushman D. W. Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents. Science 1977; 196: 441
   PubMed Web of Science ®Google Scholar
• Haber E. Renin inhibitors. N. Engl. J. Med. 1978; 298: 1023
   PubMed Web of Science ®Google Scholar
• Johnson J. A., Davis J. O., Gotschall R. W., Lohmeier T. E., Davis; J. L., Braverman B., Tempel G. E. Evidence for an intra-renal beta receptor in control of renin release. Am. J. Physiol. 1976; 230: 410
   PubMed Web of Science ®Google Scholar
• Zanchetti A. Hypothalamic control of circulation. The Nervous System in Arterial Hypertension, J. S. Esler. Charles C Thomas, SpringfieldIll 1976; 397
   Google Scholar
• Stella A., Zanchetti A. Effects of renal denervation on renin release in response to tilting and furosemide. Am. J. Physiol. 1977; 232: H500
   PubMed Web of Science ®Google Scholar
• Stella A., Calaresu F., Zanchetti A. Neural factors contributing to renin release during reduction in renal perfusion pressure and blood flow in cats. Clin. Sci. Mol. Med. 1976; 51(5)453
   PubMedGoogle Scholar
• Zanchetti A. S. Neural regulation of renin release: experimental evidence and clinical implications in arterial hypertension. Circulation. 1977; 56(5)691
   PubMed Web of Science ®Google Scholar
• Sesley J. E., Laragh J. H. “Prorenin” in human plasma? Methodological and physiological implications. Circ. Res. 1975; 36/37: 1, Suppl. 1
   Google Scholar
• Derkx F. H.M.V., Gool J. M. G., Wenting G. J., Verhoeven R. P., Man In't Veld A. J., Schalekamp M. A. D. H. Inactive renin in human plasma. Lancet 1976; 2: 496
   Web of Science ®Google Scholar
• Lee J. B., Crowshaw K., Takman B. H., Attrep K. A. The identification of prostaglandin E1, F2, and A2 from rabbit kidney medulla. Biochem. J. 1967; 105: 1251
   PubMed Web of Science ®Google Scholar
• Heinemann H. O., Lee J. B. Prostaglandin and blood pressure control. Am. J. Med. 1976; 61: 681
   PubMed Web of Science ®Google Scholar
• Peart W. S. The kidney as an endocrine organ. Lancet 1977; 2: 543
   PubMed Web of Science ®Google Scholar
• Moncada S., Gryglewski R. J., Bunting S., Vane J. R. A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation. Prostaglandins 1976; 12: 715
   PubMed Web of Science ®Google Scholar
• Terragno N. A., Terragno A. Role of naturally occurring vasoactive principles in hypertension: state of the art. Mayo Clin. Proc 1977; 52: 449
   PubMed Web of Science ®Google Scholar
• Anon. Kinins and blood pressure, (Editorial). Lancet 1978; 2: 663
   PubMedGoogle Scholar
• Sealey J. E., Atlas S. A., Laragh J. H. Linking the kallikrein and renin systems via activation of inactive renin. Am. J. Med. 1978; 65: 994
   PubMed Web of Science ®Google Scholar
• Soffer R. L. Angiotensin-converting enzyme and the regulation of vasoactive peptides. Annu. Rev. Biochem. 1976; 45: 73
   PubMed Web of Science ®Google Scholar
• Wong P. Y., Talamo R. C., Williams G. H., Coleman R. W. Response of the Kallikreinkinin and renin-angiotensin system to saline infusion and upright posture. J. Clin. Invest. 1975; 55: 691
   PubMed Web of Science ®Google Scholar
• Case D. B., Wallace J. M., Keim H. J., Weber M. A., Drayer J. I. M., White R. P., Sealey J. E., Laragh J. H. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over Saralasin. Am. J. Med. 1976; 61: 790
   PubMed Web of Science ®Google Scholar
• Thurston H., Swales J. D. Converting enzyme inhibitor and Saralasin infusion in rats. Evidence for an additional vasodepressor property of converting enzyme inhibitor. Circ. Res. 1978; 42: 588
   PubMed Web of Science ®Google Scholar
• Sealey J. E., Atlas S. A., Laragh J. H., Oza N. B., Ryan J. W. Human urinary kallikrein converts inactive to active renin and is a possible physiological activator of renin. Nature (London) 1978; 275: 144
   PubMed Web of Science ®Google Scholar
• Guyton A. C., et al. Nervous, reflex, and hormonal mechanisms for rapid pressure control. Basic Human Physiology: Normal Function and Mechanisms of Disease. W. B. Saunders, Philadelphia 1977; 234
   Google Scholar
• Guyton A. C., Coleman T. G., Cowley A. W., Scheel K. W., Manning R. D., Jr., Norman R. A., Jr. Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension. Hypertension Manual, J. H. Laragh, et al. Yorke Medical, New York 1974; 111
   Google Scholar
• Brown J. J., Lever A. F., Robertson J. S., Schalekamp M. A. Renal abnormality of essential hypertension. Lancet 1974; 2: 320
   PubMed Web of Science ®Google Scholar
• Page I. H. Pathogenesis of arterial hypertension. JAMA 1949; 140: 451
   PubMed Web of Science ®Google Scholar
• Bianchi G., Gatti M., Ferrari P., Picotti G. B., Columbo G., Velis O., Cusi D., Lupi G. P., Barlassina C., Brachi G., Gori D., Mazzei D. A renal abnormality as a possible cause of essential hypertension. Lancet 1979; 1: 173
   PubMed Web of Science ®Google Scholar
• Laragh J. H. Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles. Am. J. Med. 1973; 55(3)261
   PubMed Web of Science ®Google Scholar
• Robertson D., Nies A. S. Catecholamines and essential hypertension. J. S. C. Med. Assoc. 1977; 73: 519
   PubMedGoogle Scholar
• De Quattro V., Campese V., Miura Y., Meijer D. Increased plasma catecholamines in high renin hypertension. Am. J. Cardiol. 1976; 38: 801
   PubMed Web of Science ®Google Scholar
• Franco-Morselli R., Elghozi J. L., Joly E., DiGiuilio S., Meyer P. Increased plasma adrenaline concentrations in benign essential hypertension. Br. Med. J. 1977; 2: 1251
   PubMed Web of Science ®Google Scholar
• Sever P. S., Osikowska B., Birch M., Turnbridge R. D. G. Plasma-noradrenaline in essential hypertension. Lancet 1977; 1: 1078
   PubMed Web of Science ®Google Scholar
• Esler M., Julius S., Zweifler A., Randall O., Harburg E., Gardiner H., De Quattro V. Mild high-renin essential hypertension: neurogenic human hypertension?. N. Engl. J. Med. 1977; 296: 405
   PubMed Web of Science ®Google Scholar
• Esler M., Zweifler A., Randall O. Suppression of sympathetic nervous function in low-renin essential hypertension. Lancet 1976; 2: 115
   PubMed Web of Science ®Google Scholar
• Folkow B., Hallbäck M., Lundgren Y., Sivertsson R., Weiss L. Importance of adaptive changes in vascular design for establishment of primary hypertension, studied in man and in spontaneously hypertensive rats. Circ. Res. 1973; 32: 2, Suppl. 1
   PubMed Web of Science ®Google Scholar
• Julius S., Esler M. Autonomic nervous cardiovascular regulation in borderline hypertension. Am. J. Cardiol. 1975; 36: 685
   PubMed Web of Science ®Google Scholar
• Pearse A. G. E. The cytochemistry and ultrastructure of polypeptide hormone-producing cells of the APUD series and the embryologic, physiologic and pathologic implications of the concept. J. Histochem. Cytochem. 1969; 17: 303
   PubMed Web of Science ®Google Scholar
• Metz S. A., Levine R. J. Neuroendocrine tumors that secrete biologically active peptides and amines. Clin. Endocrinol. Metab. 1977; 6(3)719
   PubMedGoogle Scholar
• Levine R. J., Metz S. A. A classification of ectopic hormone-producing tumors. Ann. N. Y. Acad. Sci. 1974; 230: 533
   PubMed Web of Science ®Google Scholar
• Engelman K. Phaeochromocytoma. Clin. Endocrinol. Metab. 1977; 6(3)769
   PubMedGoogle Scholar
• Ackerman L. V., Rosai J. Adrenal gland and related paraganglia. Surgical Pathology. C. V. Mosby, St Louis 1974; 600
   Google Scholar
• Sjoerdsma A., Engelman K., Waldmann T., Cooperman L. H., Hammond W. G. Pheochromocytoma: current concepts of diagnosis and treatment. Ann. Int. Med. 1966; 65: 1302
   PubMed Web of Science ®Google Scholar
• Swerdloff R. S. Pheochromocytomas. Calif. Med. 1972; 117: 44
   Google Scholar
• Steinwald O. P., Doolas A., Southwick H. W. Pheochromocytoma. Surg. Clin. North Am. 1969; 49(1)87
   PubMed Web of Science ®Google Scholar
• Engelman K., Mueller P. S., Sjoerdsma A. Elevated plasma free fatty acid concentrations in patients with pheochromocytoma. N. Engl. J. Med. 1964; 270: 865
   PubMed Web of Science ®Google Scholar
• Thurston H., Bing R. F., Pohl J. E. F., Swales J. D. Renin subgroups in essential hypertension: an analysis and critique. Q. J. Med. 1978; 47(187)325
   PubMedGoogle Scholar
• Kaplan N. M. Renin profiles: the unfulfilled promises. JAMA 1977; 238: 611
   PubMed Web of Science ®Google Scholar
• Laragh J. H. Modern system for treating high blood pressure based on renin profiling and vaso-constriction-volume analysis: a primary role for beta-blocking drugs such as Propranolol. Am. J. Med. 1976; 61: 797
   PubMed Web of Science ®Google Scholar
• Brunner H. R., Laragh J. H., Baer L., Newton M. A., Goodwin F. T., Krakoff L. R., Bard R. H., Bühler F. R. Essential hypertension: renin and aldosterone, heart attack and stroke. N. Engl. J. Med. 1972; 286: 441
   PubMed Web of Science ®Google Scholar
• Miller E. D., Jr., Samuels A., Haber E., Barger A. C. Inhibition of angiotensin conversion and prevention of renovascular hypertension. Am. J. Physiol. 1975; 228: 448
   PubMed Web of Science ®Google Scholar
• Pals D. T., Masucci F. D., Denning G. S., Jr., Dipos F., Fessler D. C. Role of the pressor action of angiotensin II in experimental hypertension. Circ. Res. 1971; 29: 673
   PubMed Web of Science ®Google Scholar
• Gavras H., Brunner H. R., Vaughan E., Jr., Laragh J. H. Angiotensin-sodium interaction in blood pressure maintenance of renal hypertensive and normotensive rats. Science 1973; 180: 1369
   PubMed Web of Science ®Google Scholar
• Brunner H. R., Kirshman J. D., Sealey J. E., Laragh J. H. Hypertension of renal origin. Evidence for two different mechanisms. Science 1971; 174: 1344
   PubMed Web of Science ®Google Scholar
• Laragh J. H., Sealey J. E., Bühler F. R., Vaughan E. D., Brunner H. R., Garvas H., Baer L. The renin axis and vasoconstriction volume analysis for understanding and treating renovascular and renal hypertension. Am. J. Med. 1975; 58: 4
   PubMed Web of Science ®Google Scholar
• Beretta-Piccoli C., Weidmann P., de Chatel R., Reubi F. Hypertension associated with early stage kidney disease; complementary roles of circulating renin, the body sodium/volume state and duration of hypertension. Am. J. Med. 1976; 61: 739
   PubMed Web of Science ®Google Scholar
• Brunner H. R., Wauters J. P., McKinstry D., Waeber B., Turini G., Gavras H. Inappropriate renin secretion unmasked by Captopril (SQ14225) in hypertension of chronic renal failure. Lancet 1978; 2: 704
   PubMed Web of Science ®Google Scholar
• Linas S. L., Miller P. D., McDonald K. M., Stables D. P., Katz F., Weil R., Schrier R. W. Role of the renin-angiotensin system in post-transplantation hypertension in patients with multiple kidneys. N. Engl. J. Med. 1978; 298: 1440
   PubMed Web of Science ®Google Scholar
• Noth R. H. Interpretation of plasma renin activity. Arch. Int. Med. 1978; 138: 528
   PubMedGoogle Scholar
• Dunn M. J., Tannen R. L. Low-renin hypertension. Kidney Int. 1974; 5: 317
   PubMed Web of Science ®Google Scholar
• Gavras H., Brunner H. R., Turini G. A. Antihypertensive effect of the oral angiotensin converting-enzyme inhibitor SQ 14225 in man. N. Engl. J. Med. 1978; 298: 991
   PubMed Web of Science ®Google Scholar
• Youngberg S. P., Sheps S. G., Strong C. G. Management of the patient with renovascular hypertension. Am. Heart J. 1977; 94: 785
   PubMed Web of Science ®Google Scholar
• Harrison E. G., Jr., McCormack C. J. Pathologic classification of atherosclerotic renovascular disease. Am. J. Cardiol. 1968; 21: 60
   PubMedGoogle Scholar
• Conn J. W., Cohen E. L., Lucas C. P., McDonald W. J., Mayor G. H., Blough W. M., Jr., Eveland W. C., Bookstein J. J., Lapides J. Primary reninism, hypertension, hyperreninemia and secondary aldosteronism due to renin producing juxtaglomerular cell tumors. Arch. Int. Med. 1972; 130: 682
   PubMed Web of Science ®Google Scholar
• Ganguly A., Gribble J., Tune B., Kampson R. L., Leutscher J. A. Renin-secreting Wilms' tumor with severe hypertension. Ann. Int. Med. 1973; 79: 835
   PubMed Web of Science ®Google Scholar
• Hauger-Klevene J. H. High plasma renin activity in an oat cell carcinoma: a renin-secreting carcinoma?. Cancer (Philadelphia) 1970; 26: 1112
   PubMed Web of Science ®Google Scholar
• Vaughan E. D., Jr., Bühler F. R., Laragh J. H., Sealey J. E., Baer L., Bard R. H. Renovascular hypertension: renin measurements to indicate hypersecretion and contralateral suppression, estimate renal plasma flow, and score for surgical curability. Am. J. Med. 1973; 55: 402
   PubMed Web of Science ®Google Scholar
• Simon N., Franklin S. S., Bleifer K. H., Maxwell M. H. Clinical characteristics of renovascular hypertension. JAMA 1972; 220: 1209
   PubMed Web of Science ®Google Scholar
• Lee M. R. Renin-secreting kidney tumors. Lancet 1971; 2: 254
   PubMed Web of Science ®Google Scholar
• Ledingham J. M. The etiology of hypertension. Practitioner 1971; 207: 5
   PubMedGoogle Scholar
• Biglieri E. G., Stockigt J. R., Schambelan M. Adrenal mineralocorticoids causing hypertension. Am. J. Med. 1972; 52: 623
   PubMed Web of Science ®Google Scholar
• Biglieri E. G. Mineralocorticoids and hypertension. Hosp. Pract. 1974; 9(9)121
   Web of Science ®Google Scholar
• Bongiovanni A. M., Root A. W. The adrenogenital syndrome. N. Engl. J. Med. 1963; 268: 1342–1391; 1283
   PubMedGoogle Scholar
• Hoefnagels W. H. L., Hofman J. A., Smals A. G. H., Drayer J. I. M., Kloppenborg P. W. C., Benraad T., Jr. Dexamethazone-responsive hypertension in young women with suppressed renin and aldosterone. Lancet 1978; 1: 741
   PubMed Web of Science ®Google Scholar
• Epstein M. T., Espiner E. A., Donald R. A., Hughes H. Liquorice toxicity and the renin-angiotensin-aldosterone axis in man. Br. Med. J. 1977; 1: 209
   PubMedGoogle Scholar
• Baer L., Sommers S. C., Krakoff L. R., Newton M. A., Laragh J. H. Pseudoprimary aldosteronism. An entity distinct from true primary aldosteronism. Circ. Res. 1970; 27: 203, Suppl. 1
   PubMed Web of Science ®Google Scholar
• Melby J. C. Solving the adrenal(s) lesion of primary aldosteronism. N. Engl. J. Med. 1976; 294: 441
   PubMed Web of Science ®Google Scholar
• Hunt T. K., Schambelan M., Biglieri E. G. Selection of patients and operative approach in primary aldosteronism. Ann. Surg. 1975; 182: 353
   PubMed Web of Science ®Google Scholar
• Weinberger M. H., Grim C. E., Hollifield J. W., Kem D. C., Ganguly A., Kramer N. J., Yune H. Y., Wellman H., Donohue J. P. Primary aldosteronism: diagnosis, localization and treatment. Ann. Int. Med. 1979; 90: 386
   PubMed Web of Science ®Google Scholar
• Sutherland D. J. A., Ruse J. L., Laidlaw J. C. Hypertension, increased aldosterone secretion, and low plasma renin activity relieved by dexamethazone. Can. Med. Assoc. J. 1966; 95: 1109
   PubMed Web of Science ®Google Scholar
• Aitchison J., Brown J. J., Ferriss J. B., Fraser R., Kay A. W., Lever A. F., Neville A. M., Symington T., Robertson J. I. S. Quadric analysis in the preoperative distinction between patients with and without adrenocortical tumors in hypertension with aldosterone excess and low plasma renin. Am. Heart J. 1971; 82: 660
   PubMed Web of Science ®Google Scholar
• Epstein M. T., Espiner E. A., Donald R. A., Hughes H. Effect of eating liquorice on the renin angiotensin aldosterone axis in normal subjects. Br. Med. J. 1977; 1: 488
   PubMed Web of Science ®Google Scholar
• Baer L. Screening for adrenal forms of hypertension. Bull. N. Y. Acad. Sci. 1976; 52: 690
   PubMedGoogle Scholar
• Feinstein A. R. An analysis of diagnostic reasoning. I. The domains and disorders of clinical macrobiology. Yale J. Biol. Med. 1973; 46: 212
   PubMed Web of Science ®Google Scholar
• Burke M. D. Laboratory tests: basic concepts and realistic expectations. Postgrad. Med. 1978; 63: 53
   PubMed Web of Science ®Google Scholar
• Young D. S. Factors influencing the concentrations of serum constituents in well individuals. Med. Instrum. (Baltimore) 1974; 8: 9
   PubMedGoogle Scholar
• Werner M., Brooks S. H., Wette R. Strategy for cost-effective laboratory testing. Hum. Pathol. 1973; 4: 17
   PubMed Web of Science ®Google Scholar
• Galen R. S., Gambino S. R. Beyond Normality: The Predictive Value and Efficiency of Medical Diagnosis. John Wiley & Sons, New York 1975; 30: 62
   Google Scholar
• Burke M. D. Diagnosis: art or science?. Diagn. Med. 1978; 1: 25
   Google Scholar
• Pauker S. G, Kassirer J. P. Therapeutic decision-making: a cost-benefit analysis. N. Engl. J. Med. 1975; 293: 229
   PubMed Web of Science ®Google Scholar
• Sackett D. L., Holland W. W. Controversy in the detection of disease. Lancet 1975; 2: 357
   PubMed Web of Science ®Google Scholar
• Anon. Symptoms in hypertension (Editorial). Br. Med. J. 1976; 3: 1551
   Google Scholar
• Simpson F. Hypertension. Br. Med. J. 1978; 2: 882
   PubMed Web of Science ®Google Scholar
• Tolis G., Kuchel O. The multiple faces of pheochromocytoma. Can. Med. Assoc. J. 1977; 116: 337
   PubMed Web of Science ®Google Scholar
• Packman R. C., O'Neal L. W., Wessler S., Avioli L. V. Pheochromocytoma. JAMA 1970; 212: 780
   PubMed Web of Science ®Google Scholar
• Reid J. L., Jones D. H., Dollery C. T. Plasma-catecholamines in phaeochromocytoma. Lancet 1976; 2: 1021
   PubMed Web of Science ®Google Scholar
• Gitlow S. E., Mendlowitz M., Bertani L. M. The biochemical techniques for detecting and establishing the presence of a pheochromocytoma. Am. J. Cardiol. 1970; 26: 270
   PubMed Web of Science ®Google Scholar
• Rock R. C. Urinary Metanephrines, Check Sample, Advanced Clinical Chemistry No. ACC-26. CCE Council on Clinical Chemistry. American Association of Clinical Pathologists, Chicago 1978
   Google Scholar
• Amery A., Conway J. A critical review of diagnostic tests for pheochromocytoma. Am. Heart, J. 1967; 73: 129
   PubMed Web of Science ®Google Scholar
• Young D. S., Pestaner L. C., Gibberman V. Effects of drugs on clinical laboratory tests. Clin. Chem. 1975; 21(5)1D
   PubMed Web of Science ®Google Scholar
• Hamilton B., Landsberg L., Levine R. J. Measurement of urinary epinephrine in screening for pheochromocytoma in multiple endocrine neoplasia Type II. Am. J. Med. 1978; 65: 1027
   PubMed Web of Science ®Google Scholar
• Weinstein M. C., Fineberg H. V. Cost-effectiveness analysis for medical practices: appropriate laboratory utilization. Logic and Economics of Clinical Laboratory Use Benson, E. S. and Rubin, M., Eds. Elsevier, Amsterdam 1978; 3
   Google Scholar
• Re R., Novelline R., Escourrou M. T., Athanasoulis C., Burton J., Haber E. Inhibition of angiotensin-converting enzyme for diagnosis of renal-artery stenosis. N. Engl. J. Med. 1978; 298: 582
   PubMed Web of Science ®Google Scholar
• Baer L., Parra-Carrillo J. Z., Radichevich I., Williams G. S. Detection of renovascular hypertension with angiotensin II blockade. Ann. Int. Med. 1977; 86: 257
   PubMed Web of Science ®Google Scholar
• McDonald J. M., Ladenson J. H. Renovascular hypertension and plasma renin activity. Clin. Chem. 1979; 25: 289
   PubMed Web of Science ®Google Scholar
• Oparil S. Theoretical approaches to estimation of plasma renin activity: a review and some original observations. Clin. Chem. 1976; 22: 583
   PubMed Web of Science ®Google Scholar
• Delorme A., Guyene P. T., Corvol P., Menard J. Methodologic problems in plasma renin activity measurements. Am. J. Med. 1976; 61: 725
   PubMed Web of Science ®Google Scholar
• Bangham D. R., Robertson I., Robertson J. S., Robinson C. J., Tree M. An international collaborative study of renin assay: establishment of the international reference preparation of human renin. Clin. Sci. Mol. Med. 1975; 48: 135s
   Google Scholar
• Sealey J. E., Moon C., Laragh J. H. Plasma prorenin in normal, hypertensive and anephric subjects and its effects on renin measurements. Circ. Res. 1977; 40: 41, Suppl. 1
   PubMed Web of Science ®Google Scholar
• Fyhrquist F., Puutula L. Effect of temperature on plasma renin samples. Clin. Chem. 1978; 24: 1202
   PubMed Web of Science ®Google Scholar
• Wallach L., Nyarai I., Dawson K. G. Stimulated renin: a screening test for hypertension. Ann. Int. Med. 1975; 82: 27
   PubMed Web of Science ®Google Scholar
• Kaplan N. M., Kem D. C., Holland O. B., Kramer N. J., Higgens J., Gomez-Sanchez C. The intravenous furosemide test: a simple way to evaluate renin responsiveness. Ann. Int. Med. 1976; 84: 639
   PubMed Web of Science ®Google Scholar
• Mitchell J. R., Taylor A. A., Pool J. L., Lake C. R., Rollins D. E., Bartter F. C. Reninaldosterone profiling in hypertension. Ann. Int. Med. 1977; 87: 596
   PubMed Web of Science ®Google Scholar
• Seldinger S. I. Catheter replacement of the needle in percutaneous arteriography: a new technique. Acta Radiol. 1953; 39: 368
   PubMed Web of Science ®Google Scholar
• Russell R. P. Renal hypertension. Surg. Clin. North Am. 1974; 54: 349
   PubMed Web of Science ®Google Scholar
• Whelton P. K., Harrington D. P., Russell R. P., White R. I., Walker W. G. Renal vein renin activity: a prospective study of sampling techniques and methods of interpretation. Johns Hopkins Med. J. 1977; 141: 112
   PubMedGoogle Scholar
• Maxwell M. H., Marks L. S., Lupu A. N., Cahill P. J., Franklin S. S., Kaufman J. J. Predictive value of renin determinations in renal artery stenosis. JAMA 1977; 238: 2617
   PubMed Web of Science ®Google Scholar
• Gunnells J. C., McGuffin W. L., Johnsrude I., Robinson R. R. Peripheral and renal venous plasma renin activity in hypertension. Ann. Int. Med. 1969; 71: 555
   PubMed Web of Science ®Google Scholar
• Stockigt J. R., Noakes C. A., Collins R. D., Schambelan M., Biglieri E. G. Renal vein renin in various forms of renal hypertension. Am. J. Cardiol. 1973; 32: 707
   PubMedGoogle Scholar
• Bookstein J. J., Abrams H. L., Buenger R. B., Lecky J., Franklin S. S., Reiss M. D., Bleiffer K. H., Klatte E. C., Varady P. D., Maxwell M. H. Radiological aspects of renovascular hypertension. II. The role of urography in unilateral renovascular disease. JAMA 1972; 220: 1225
   PubMed Web of Science ®Google Scholar
• Foster J. H., Oates J. A. Recognition and management of renovascular hypertension. Hosp. Pract. 1975; 10(10)61
   Google Scholar
• Breslin D. J., Swinton N. W. Renovascular hypertension: surgical versus medical therapeutic considerations. Med. Clin. North Am. 1979; 63: 397
   PubMed Web of Science ®Google Scholar
• Shapiro A. P., McDonald R. H., Scheib E. Renal arterial stenosis and hypertension. II. Current criteria for surgery. Am. J. Cardiol. 1976; 37: 1065
   PubMed Web of Science ®Google Scholar
• Eddy R. L., Jones A. L., Gilliland P. F., Ibarra J. D., Jr., Thompson J. Q., McMurray J. F., Jr. Cushing's syndrome: a prospective study of diagnostic methods. Am. J. Med. 1973; 55: 621
   PubMed Web of Science ®Google Scholar
• Brodie A. H., Shimizu N., Tait S. A. S., Tait J. F. A method for the measurement of aldosterone in peripheral plasma using H-acetic anhydride. J. Clin. Endocrinol. 1967; 27: 997
   Web of Science ®Google Scholar
• Ito T., Woo J., Haning R., Morton R. A radioimmunoassay for aldosterone in human peripheral plasma, including a comparison of alternate techniques. J. Clin. Endocrinol. Metab. 1972; 34: 106
   PubMed Web of Science ®Google Scholar
• Kubasik N. P., Warren K., Sine H. E. Evaluation of a new commercial radioassay kit for aldosterone using an iodinated tracer. Clin. Biochem. 1979; 12(2)59
   PubMed Web of Science ®Google Scholar
• Melby J. C. Extensive hypertensive work-up: pro. JAMA 1975; 231: 399
   PubMed Web of Science ®Google Scholar
• Kaplan N. M. Clinical Hypertension. Medcom, New York 1973
   Google Scholar
• Kem D. C., Weinberger M. H., Mayes D. M., Nugent C. A. Saline suppression of plasma aldosterone in hypertension. Arch. Intern. Med. 1971; 128: 380
   PubMed Web of Science ®Google Scholar
• Hollifield J. W. Distinguishing primary aldosteronism caused by adenoma from adrenal hyperplasia. Tenn. Med. Assoc. J. 1978; 71(1)47
   PubMedGoogle Scholar
• Ferriss J. B., Brown J. J., Fraser R., Kay A. W., Neville A. M., O'Muircheartaigh I. G., Robertson J. I. S., Symington T., Lever A. F. Hypertension with aldosterone excess and low plasma renin: preoperative distinction between patients with and without adrenocortical tumour. Lancet 1970; 2: 995
   PubMed Web of Science ®Google Scholar
• Sheps S. G., Kirkpatrick R. A. Hypertension. Mayo Clin. Proc. 1975; 50: 709
   PubMed Web of Science ®Google Scholar
• Weinberger M. H. Oral contraceptives and hypertension. Hosp. Pract. 1975; 10(5)65
   Google Scholar
• Fisch I. R., Frank M. A. Oral contraceptives and blood pressure. JAMA 1977; 237: 2499
   PubMed Web of Science ®Google Scholar
• Knuth D. E. Algorithms. Sci. Am. 1977; 236: 63
   Web of Science ®Google Scholar
• Maronde R. F. The hypertensive patient: an algorithm for diagnostic work-up. JAMA 1975; 233: 997
   PubMed Web of Science ®Google Scholar
• Grim C. E., Weinberger M. H., Higgins J. T., Kramer N. J. Diagnosis of secondary forms of hypertension: a comprehensive protocol. JAMA 1977; 237: 1331
   PubMed Web of Science ®Google Scholar
• Laragh J. H., Letcher R. L., Pickering T. G. Renin profiling for diagnosis and treatment of hypertension. JAMA 1979; 241: 151
   PubMed Web of Science ®Google Scholar
• Pickering M. J. Evaluation of hypertension. Fla. Med. Assoc. J. 1976; 63: 975
   PubMedGoogle Scholar
• Bartha G. W., Nugent C. A. Routine chest roentgenograms and electrocardiograms: usefulness in the hypertensive work-up. Arch. Int. Med. 1978; 138: 1211
   PubMedGoogle Scholar
• Foster J. H., Maxwell M. H., Franklin S. S., Bleiffer K. H., Trippel O. H., Julian O. C., De Camp P. T., Varady P. D. Renovascular occlusive disease: results of operative treatment. JAMA 1975; 231: 1043
   PubMed Web of Science ®Google Scholar
• Ernst C. B., Stanley J. C., Marshall F. F., Fry W. J. Renal revascularization for arteriosclerotic renovascular hypertension: prognostic implications of focal renal arterial vs. overt generalized arteriosclerosis. Surgery 1973; 73: 859
   PubMed Web of Science ®Google Scholar